889

N-{6,6-DIMETHYL-5-[(1-METHYLPIPERIDIN-4-YL)CARBONYL]-1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOL-3-YL}-3-METHYLBUTANAMIDE

Created:	2009-08-03
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where 889 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	0
Bond Count	59
Aromatic Bond Count	5

2D diagram of 889

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{6,6-DIMETHYL-5-[(1-METHYLPIPERIDIN-4-YL)CARBONYL]-1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOL-3-YL}-3-METHYLBUTANAMIDE
Systematic Name (OpenEye OEToolkits)	N-[6,6-dimethyl-5-(1-methylpiperidin-4-yl)carbonyl-1,4-dihydropyrrolo[4,3-d]pyrazol-3-yl]-3-methyl-butanamide
Formula	C₁₉ H₃₁ N₅ O₂
Molecular Weight	361.482
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(N2C(c1nnc(NC(=O)CC(C)C)c1C2)(C)C)C3CCN(C)CC3
SMILES	CACTVS	3.352	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C3CCN(C)CC3)C2(C)C
SMILES	OpenEye OEToolkits	1.6.1	CC(C)CC(=O)Nc1c2c([nH]n1)C(N(C2)C(=O)C3CCN(CC3)C)(C)C
Canonical SMILES	CACTVS	3.352	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C3CCN(C)CC3)C2(C)C
Canonical SMILES	OpenEye OEToolkits	1.6.1	CC(C)CC(=O)Nc1c2c([nH]n1)C(N(C2)C(=O)C3CCN(CC3)C)(C)C
InChI	InChI	1.03	InChI=1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25)
InChIKey	InChI	1.03	HUXYBQXJVXOMKX-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB12686
Name	PHA-793887
Groups	investigational
Description	PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.
Synonyms	PHA-793887
Categories	Cyclin-Dependent Kinases, antagonists & inhibitors
CAS number	718630-59-2

Related Resource References

Resource Name	Reference
Pharos	CHEMBL1230607
PubChem	46191454
ChEMBL	CHEMBL1230607
ChEBI	CHEBI:91371

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.